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results reported in the literature, is not due solely to 
statistical misuse but is real and is interesting yet is not 
discussed by Lagrange et al. It is most probably due 
to the timing of the serologic tests. A60 antigen is 
dominant during human disease and serologic testing 
with A60 is applied to patients who consult because 
they have symptoms; the serologic results obtained 
must be evaluated together with clinical clues, as 
recommended. The criteria for selection of patients 
and controls applied by Lagrange et a1 are not stated. 
Presumably the search was diverted towards asymp- 
tomatic TB cases in conjunction with suspicion of 
HIV infection. One may safely predict that the fre- 
quency of anti-A60 seropositives would increase with 
the appearance of symptoms and also in HIV-positive 
cases with chronic TB, while the frequency of positive 
cases detected with the non-peptide antigens would be 
higher in healthy people with no other sign of infection, 
with an extension of the search to TB-risk groups. 
Sixth, a most disturbing aspect of this comparative 
analysis is the absence of publication of the D T H  data 
that were collected on TB patients. Lagrange et al. 
omitted this search in control groups, thereby ignoring 
the possibility of BCG vaccinations and inapparent or 
past infections. Equally worrying is the absence of 
statistical analysis on the usefulness of combing protein 
antigens with non-peptide antigen in ELISA. Such 
information could have been provided and would have 
contributed substantially to our understanding of the 
immunologic processes and also, if an additive effect 
were observed, improved the system of detection. 
Kesearch into human tuberculosis is difficult and 
frustrating. The investigation of Lagrange et a1 repre- 
sents a welcome departure from traditional research 
concerns, even if it presents substantial deficiencies. It 
contributes to a better understanding of the immuno- 
pathology of the disease. In the face of discrepant 
findings, what must be avoided now is a grand sweep 
of induction that extracts general laws from limited 
observations with preparations the properties of which 
have not yet been completely defined. 
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The object of this study was to compare the relative 
efficiency of different peptide and non-peptide antigens 
in an ELISA test in hospitalized patients presenting 
with mycobacterial disease and with a bacteriologically 
proven diagnosis. The controls were healthy blood 
donors without dagnosed tuberculosis and not treated 
during the preceding 5 years. The controls with 
pulmonary afAictions were patients whose samples 
(expectoration, bronchoscopy, bronchoalveolar lavage), 
including the repeats, turned out to be negative. None 
of them had received antituberculosis antibiotic therapy. 
The notion of HIV seropositivity was included in this 
study only retrospectively, on the basis of patient 
records, in order to verify whether these ELISA tests 
were applicable to all cases in which active tuberculosis 
had been diagnosed, and independently of the know- 
ledge of the immune status with respect to HIV. 
Demonstration of anti-A60 IgA was not attempted in 
this study since the only document published at the 
time of our study was that by Gupta et a1 [l] which 
showed equivalence between IgG and IgA. This has 
been subsequently confirmed in an Italian study 121. 
Furthermore, the recommendation to test for anti-A60 
IgA in HIV-positive subjects does not seem to be 
documented, and in any case, does not appear in the 
two above-mentioned publications. 
As far as the absence of graduation of the ordinate 
in Figures 1 and 2 is concerned, this is a typographical 
error. At any rate, this is of little importance and the 
cut-off levels are indicated. These have not been chosen 
randomly, but have been calculated according to 
established procedures using the mean of the results 
of the ODs of the blood donors plus two standard 
deviations. These cut-off levels, and in particular those 
for anti-A60 IgGs, are identical to those found by other 
authors [2]. They have been given in Tables 2 to 5. 
The conditions for reading the ELISA A60 plates were 
those recommended by the manufacturer and readings 
were done at 450 nm, and not at 414 nm, the wave- 
length used exclusively for the reading of ELISAs using 
the glycolipid antigens. The use of these cut-off levels 
has allowed the comparison of the sensitivities of 
the different tests, using one comparable specificity. 
Furthermore, the comparison of the means of the 
antibody titers, in various clinical-biological situations 
(pulmonary and extrapulmonary tuberculosis, sero- 
positivity and -negativity with respect to HIV, positive 
or negative direct examination) has been carried out 
in order to attempt the evaluation of the influence of 
these situations on the antibody response measured by 
the OD with respect to each antigen tested. As has 
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been mentioned in the text, in the context of the 
methodology of calculation used (ref. 19), these ODs 
correspond to ODs corrected with respect to those of 
the wells without serum. The expression of such low 
mean values in certain groups corresponds to the 
absence of antibodies within these groups. Further- 
more, as for certain results of these means, these are 
acconipanied by an important standard error which 
corresponds to the calculation linked to the distribution 
of the results, as shown in Figures 1 and 2. 
As far as the specificity of the ELISA tests is 
concerned, which was evaluated from sera of patients 
who were HIV positive but presented with atypical 
mycobacterial disease, only those patients who had 
suffered disseminated disease (diagnosed from positive 
blood cultures) were tested. There is therefore an error 
in the sentence cited on page 219, which should 
read: ‘such reduced specificity was not observed when 
ELISA for A60 antigen was performed in these 
pathologic sera but was 83.3% in HIV-positive patients 
with disseminated M O T T  infection’. The lesser speci- 
ficity of the ELISA tests using the glycolipids of 
M.  tuberculosis in these patients is discussed and does 
not seem to be due to the detection of cross-reactive 
antigens of M .  avium and M. tuberculosis. The argument 
given by Dr Maes concerning the presence of anti- 
DAT antibodies in the serum of patients afflicted with 
leprosy does not allow the deduction of a cross- 
reaction, but of the possibility of co-infection with M. 
tuberculosis and M. leprae as has been described in HIV- 
positive patients for M .  tuberculosis and M .  avium [3]. 
Finally, the search for sensitization to tuberculin 
measured by a tuberculin skin test, showing evidence 
of a previous vaccination with BCG in the control 
patients, or of a previous primary infection, does not 
allow a better comparison of the tests. Furthermore, it 
had been shown that vaccination with BCG did not 
influence the serologic responses measured with an 
ELISA test using the glycolipids specific for M.  
tuberculosis [4]. This, by the way, has been verified in a 
study actually carried out in children. Finally, in the 
study ofAlifano et a1 [2], the PPD+ and PPD- controls 
have strictly identical anti-A60 IgG or IgA responses. 
In conclusion, the present study had as its essential 
aim to compare, in a population of patients with 
documented tuberculous disease (culture-positive), the 
diagnostic efficiency of ELISA tests using peptide and 
other, different clinical-biological situations, in order 
to evaluate the capacity of these tests in the different 
situations which one encounters in hospitalized patients 
suspected of having tuberculosis, in particular when 
the direct bacteriologic diagnosis (Ziehl-Neelsen) is 
negative and independent of the immune status with 
respect to HIV As suggested, we calculated, on the basis 
of the available data, the positive results obtained with 
ELISA A60 and ELISA using anti-glycolipids. We could 
observe an increase in the sensitivity of the tests in 
HIV-seronegative tuberculosis patients (+ 12%), but 
no increase in HIV-seropositive tuberculosis patients. 
These data indicate that the serologic responses to 
peptides are different from those induced by the 
glycolipids: certain patients develop a response to the 
peptides but not to the glycopeptides and vice versa. 
No physiopathologic explanation is known for such an 
observation, but the use of protein antigen in con- 
junction with glycolipid antigen in the analysis of the 
serologic responses in the course of tuberculosis has 
been recommended 151. 
7 
I? H. Lagrange 
Service de Microbiologie, 
Hbpital Saint-Louis, 
1 avenue Claude Vellefaux, 
4547 Paris Cedex 10, France 
References 
1. Gupta S, Kumari S, Banwalikar JN, Gupta SK. Diagnostic 
utility of the estimation of niycobacterial antigen A60 
specific immunoglobulins IgM, IgA and IgG in the sera of 
cases of adult human tuberculosis. Tubercle Lung Dis 1995; 
2. Alifano M, Sofia M, Morbile M et al. IgA immune response 
against the niycobacterial antigen A60 in patients with active 
pulmonary tuberculosis. Respiration 1996; 63: 292-7. 
3. Epstein MU, Aranda CP, Bonk S, Hanna €3, Rom WM. The 
significance of Mycobacterium avium complex cultivation in 
the spectrum of patients with pulmonary tuberculosis. Cheyt 
4. Salem JR, Costa MF, Cruaud P, David HL. Does previous 
BCG vaccination interfere with the serodiagnosiy of tuber- 
culosis using Mycobacterium tubPrculosis specific glycolipid 
antigens? Int J Leprosy 1992; 60: 87-9. 
5. Chan SL, Reggiardo Z, Daniel TM, Girling UJ. Mitchison 
DA. Serodiagnosis of tuberculosis using an ELISA with 
antigen 5 and a hemagglutination assay with glycolipid anti- 
gens. Results in patients with newly diagnosed pulmonary 
tuberculosis ranging in extent of &ease from minimal to 
76: 418-24. 
1997; 111: 142-7. 
non-peptide antigens and to compare, against each extensive. Am Res Respir Dis 1990; 142: 385-9 
